Mutated JAK kinases and deregulated STAT activity are potential therapeutic targets in cutaneous T-cell lymphoma.
Pérez C, González-Rincón J, Onaindia A, Almaráz C, García-Díaz N, Pisonero H, Curiel-Olmo S, Gómez S, Cereceda L, Madureira R, Hospital M, Suárez-Massa D, Rodriguez-Peralto JL, Postigo C, Leon-Castillo A, González-Vela C, Martinez N, Ortiz-Romero P, Sánchez-Beato M, Piris MÁ, Vaqué JP.
Pérez C, et al.
Haematologica. 2015 Nov;100(11):e450-3. doi: 10.3324/haematol.2015.132837. Epub 2015 Aug 20.
Haematologica. 2015.
PMID: 26294736
Free PMC article.
No abstract available.